1.25 USD
+0.00 (+0.00%)
AT CLOSE (11:59 AM EDT)
Tiziana Life Sciences Ltd. Common Shares (TLSA)
NASDAQ: TLSA • USD
1.25
+0.01 (+0.40%)
POST MARKET (AS OF 05:00 PM EDT)
Market: OPEN
Open?$1.24
High?$1.28
Low?$1.21
Prev. Close?$1.25
Volume?111.1K
Avg. Volume?N/A
VWAP?$1.24
Bid / Ask
Bid?$1.24 × 100
Ask?$1.26 × 100
Spread?$0.02
Midpoint?$1.25
Valuation & Ratios
Market Cap?159.1M
Shares Out?118.9M
Float?73.9M
Float %?62.2%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Related Companies
Loading...
News
Profile
Tiziana Life Sciences Ltd is a clinical stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS. Its flagship immunotherapeutic candidate, Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody, is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's and other CNS indications.